Correlation Between Pieris Pharmaceuticals and Immunic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Immunic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Immunic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and Immunic, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Immunic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Immunic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Immunic.

Diversification Opportunities for Pieris Pharmaceuticals and Immunic

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Pieris and Immunic is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Immunic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunic and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Immunic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunic has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Immunic go up and down completely randomly.

Pair Corralation between Pieris Pharmaceuticals and Immunic

Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to under-perform the Immunic. In addition to that, Pieris Pharmaceuticals is 1.41 times more volatile than Immunic. It trades about 0.0 of its total potential returns per unit of risk. Immunic is currently generating about 0.03 per unit of volatility. If you would invest  119.00  in Immunic on August 29, 2024 and sell it today you would earn a total of  1.00  from holding Immunic or generate 0.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pieris Pharmaceuticals  vs.  Immunic

 Performance 
       Timeline  
Pieris Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pieris Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Immunic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Immunic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pieris Pharmaceuticals and Immunic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pieris Pharmaceuticals and Immunic

The main advantage of trading using opposite Pieris Pharmaceuticals and Immunic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Immunic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunic will offset losses from the drop in Immunic's long position.
The idea behind Pieris Pharmaceuticals and Immunic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account